跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11 条关于
“Izelvay”
全部
11
临床试验
1
药物
0
机构
0
资讯
10
去年
EMA's CHMP Recommends Multiple New Medicines and расширения Indications in November and December 2024 Meetings
去年
FDA Issues Complete Response Letter for Astellas' Izervay sNDA
去年
FDA Issues Complete Response Letter for Astellas' IZERVAY sNDA
去年
FDA Rejects Astellas' Label Update for Geographic Atrophy Drug Izervay
10个月前
Three-Year Izervay Data Shows Sustained Reduction in Geographic Atrophy Lesion Growth
去年
FDA Approves Expanded Label for Astellas' Izervay, Removing Dosing Duration Limits for Geographic Atrophy
去年
Astellas to Present New IZERVAY Data on Geographic Atrophy at Major Ophthalmology Congresses
去年
FDA Approves Zeiss MEL 90 Excimer Laser and Accepts Revised sNDA for Izervay
去年
FDA Rejects Astellas' Izervay Update; Cytokinetics and Bayer Announce Aficamten Licensing Deal
去年
FDA Issues Complete Response Letter for Astellas' IZERVAY and Accepts Aldeyra's NDA for Reproxalap